Clobetasol Propionate Alopecia Areata

Clobetasol Propionate Alopecia Areata - A study done by The Department of Dermatology, University of Bologna, Italy shows that clobetasol propionate 0.05% under occlusion is effective in inducing hair regrowth in patients with AT or AT/alopecia universalis. Occurrence of hair regrowth only on the treated half of the scalp clearly shows that efficacy of treatment is a result of a local and not systemic effect of the drug. Although only 17.8% of patients had long-term benefit by treatment, results were obtained in a population of patients with severe and refractory forms of the disease

Clobetasol Propionate comes in ointment and emollient cream presentations. It is a very high potency topical corticosteroid that should not be used with occlusive dressings. It is recommended that treatment should be limited to 2 consecutive weeks and therapy should be discontinued when adequate results have been achieved. Clobetasol propionate is marketed and sold worldwide under numerous names including Temovate (US), Tenovate, Dermovate, Dermatovate, Butavate and, Movate.